PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea flag South Korea · Delayed Price · Currency is KRW
310,000
+11,500 (3.85%)
Apr 16, 2026, 3:30 PM KST

PharmaResearch Revenue

In the year 2025, PharmaResearch had annual revenue of 536.29B KRW with 53.18% growth. PharmaResearch had revenue of 143.35B in the quarter ending December 31, 2025, with 39.06% growth.

Revenue
536.29B
Revenue Growth
+53.18%
P/S Ratio
6.01
Revenue / Employee
1.08B
Employees
497
Market Cap
3.22T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025536.29B186.17B53.18%
Dec 31, 2024350.12B89.10B34.14%
Dec 31, 2023261.01B66.25B34.02%
Dec 31, 2022194.76B40.68B26.40%
Dec 31, 2021154.08B45.34B41.69%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Chabiotech1.27T
SK Biopharmaceuticals706.74B
SK bioscience651.37B
Hugel425.11B
LigaChem Biosciences141.55B
Pharmicell23.94B
OliX Pharmaceuticals14.67B
Voronoi7.51B
Revenue Rankings